MedTrace Logo

Comparing the Efficacy of Urinary and Recombinant Human Chorionic Gonadotropin (hCG) on Oocyte Maturity

NCT01507376 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2014-04-25

No results posted yet for this study

Summary

This study is a prospective randomized clinical trial to compare the efficacy of the urinary and recombinant hCG on oocyte quality for ovulation induction in women undergoing IVF/ICSI.

Conditions

  • In Vitro Fertilization

Interventions

DRUG

recombinant hCG

recombinant hCG(250 µg Ovitrell)

DRUG

recombinant hCG

recombinant hCG(500 µg Ovitrell)

DRUG

urinary hCG

10,000 IU urinary hCG

Sponsors & Collaborators

  • Royan Institute

    lead OTHER_GOV

Principal Investigators

  • Hamid Gourabi, PhD · Head of Royan Institute

  • Taraneh Madani, MD · gynecology scientist

  • Ladan Mohmmadi yeganeh, MSc · Investigator

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
37 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2012-09-30
Completion
2013-06-30

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01507376 on ClinicalTrials.gov